ARCHIVE

• Usefulness of Novacor LVAS Discussed: Edwards Lifesciences
  May 19, 2003

• JSMI Approves FY2003 Activity Plan
  May 19, 2003

• WORLD NEWS IN BRIEF
  May 19, 2003

• New Drugs Including Remicade, Pitavastatin Recommended for Approval
  May 19, 2003

• CAWACHI YAKUHIN: Ordinary Profits Up 17% to \10.6 Bil.
  May 19, 2003

• WEBSITE NEWS
  May 19, 2003

• Package Insert to Be Revised for Pazufloxacin, Lithium Carbonate
  May 19, 2003

• Pharmacists Needed in Discussions on OTC Deregulation: JPA
  May 19, 2003

• Terumo: Record-high Sales, Profits Attributable to Mainstays
  May 19, 2003

• Chugai Neglects Immediate PMS for Cellcept
  May 19, 2003

• Astis, 3 Partners to Establish Specialized OTC Drug Wholesaler
  May 19, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  May 19, 2003

• REGULATORY NEWS IN BRIEF
  May 19, 2003

• Meet the Leaders (19)
  May 19, 2003

• Nearly All Regulatory Reform Items for FY2002 Implemented: Reform Council
  May 19, 2003

• Eisai Initiates Post-Aricept Project
  May 19, 2003

• Iressa Safety Problems Discussed
  May 19, 2003

• Merger of Marketing Systems Going Well: Taisho Toyama
  May 19, 2003

• SARS ISSUES
  May 19, 2003

• Sankyo Introduces SAP AG's SAP R/3 Integrated Info System
  May 19, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 599
• 600
• 601
• 602
• 603
• 604
• 605
• 606
• 607
• …
• Next ›
• 最終 »